Amesite is trading 5.48% up at $0.88 on October 13, 2026, with the specific catalyst unclear.

  • Available search found no new company announcement clearly explaining the intraday rise; Amesite’s latest listed press release was September 24, about a NurseMagic enterprise sales win.
  • Current market coverage includes a director’s reported acquisition of 12,121 stock units, but available information does not establish that it caused the move.
  • The broader market was modestly lower, so it does not explain Amesite’s gain.